{
  "abstract": "Background The World Health Organisation (WHO) aims to eliminate hepatitis B (HBV) by 2030 through increased testing, wider access to treatment, and improved prevention strategies. In line with this, recent WHO and European Association for the Study of the Liver (EASL) guidance recommends broader treatment eligibility. In England, elimination efforts have been complemented by the introduction of opt-out HBV testing in emergency departments (EDs). Such recent changes have significantly expanded the HBV patient cohort in our centre. This service evaluation aims to assess the impact of an existing pharmacist-led HBV clinic and explore its potential as a sustainable model to meet rising demand.Methods Patients reviewed in the pharmacist-led viral hepatitis clinic at Guy’s and St Thomas’ NHS Foundation Trust between 1st April 2024 and 31st March 2025 were identified through the electronic patient record. Demographic and clinical data, treatment pathways, and clinic utilisation were collected and analysed.Results Over a 12-month period, 137 patients were reviewed at roughly six-monthly intervals in the pharmacist-led clinic. Of these, 81% (111) were from minority ethnic backgrounds and 62% (85) were male. All patients were over 30 years old and on long-term antiviral therapy: 51% (70) on entecavir and 49% (67) on tenofovir disoproxil. A total of 117 patients (85%) had been followed in the clinic for over three years.Most patients (90%, n=123) were also under surveillance for HCC, and 12% (n=16) were cirrhotic, with only 19% (n=3) of these under parallel medical review. In total, 11% (n=15) were co-managed with other MDT members.The clinic currently has capacity to manage over 200 patients, but only 137 are have been seen in the last year. If capacity was maximised 70 more patients could be seen, saving 140 consultant appointments per year.Conclusion Pharmacists are not only experts in medicines but also in supporting adherence in chronic disease. Chronic hepatitis B care presents an ideal opportunity for pharmacy-led services, as demonstrated in this evaluation, where patients are being managed mostly independently for a range of long-term clinical needs.Wider adoption and referral to pharmacist-led clinics could be a key enabler in achieving HBV elimination goals within existing resources.",
  "authors": [
    {
      "affiliations": [
        "Guys And St Thomas’ NHS Trust, UK"
      ],
      "name": "Sinead Peare"
    },
    {
      "affiliations": [
        "Guys And St Thomas’ NHS Trust, UK"
      ],
      "name": "Kartikeya Khanna"
    },
    {
      "affiliations": [
        "Guys And St Thomas’ NHS Trust, UK"
      ],
      "name": "Susanne Johansen"
    },
    {
      "affiliations": [
        "Guys And St Thomas’ NHS Trust, UK"
      ],
      "name": "Carmen Hendy"
    },
    {
      "affiliations": [
        "Guys And St Thomas’ NHS Trust, UK"
      ],
      "name": "Bo Wang"
    }
  ],
  "title": "P134 Pharmacist-led hepatitis B clinics: a sustainable model for workforce optimisation in response to WHO and EASL guidance",
  "uid": "05f6e316-2941-56a2-96e3-2ff248e466a2"
}